HCA expects third-quarter revenues of $9.22 billion, up from $8.46 billion in the third quarter of 2013. Adjusted EBITDA for the quarter is projected to be approximately $1.83 billion, compared with approximately $1.6 billion in 2013. These financial results are still subject to finalization of HCA’s quarterly financial and accounting procedures. The company expects to report its complete third-quarter financial results on or around Oct. 28.
HCA has also increased its 2014 guidance. Revenues are now expected to reach $36.5 billion to $37 billion, up from the $36 billion to $36.5 billion projected in the company’s July 2014 guidance. Adjusted EBITDA is now projected to be $7.25 billion to 7.35 billion, up from $7 billion to $7.15 billion.
The revised guidance takes into account various factors, such as an expected 4 percent benefit to adjusted EBITDA from the Patient Protection and Affordable Care Act and estimated EHR incentive income assumptions of $110 million to $130 million.
More articles on HCA:
HCA to close Edward White Hospital in Florida
HCA signs agreement to purchase PatientKeeper
HCA faces class-action lawsuit over 2011 IPO
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
